Abbottabad hospital to conduct drug trials on COVID-19 patients

PESHAWAR: The US National Institute of Health has approved a proposal of medical teaching institution Ayub Medical College and Ayub Teaching Hospital Abbottabad to conduct trial on Covid-19 patients to find out treatment for the pandemic, which has no cure so far.

The trial entitled “effectiveness of hydroxychloroquine in Covid-19 patients” was approved by the US National Library of Medicine of National Institute of Health (NIH), last month to try different set of medicines for the treatment of Covid-19 patients.

Prof Umar Farooq, dean and chief executive officer of Ayub Medical College (AMC) and Ayub Teaching Hospital (ATH) Abbottabad, who will lead the trial, said that they had begun work and were hopeful of success.

“There is no timeline about completion of trial as it depends on the number of patients we receive. Approval of our proposal is an indication of the ability of our team and its success would benefit the entire world,” he said.

Leave a Reply

avatar
  Subscribe  
Notify of
Share via
Copy link
Powered by Social Snap
%d bloggers like this: